Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.

• Necchi A Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it.
• Mariani L Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
• Lo Vullo S Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
• Yu EY University of Washington, Seattle, WA, USA.
• Woods ME University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA.
• Wong YN Fox Chase Cancer Center, Philadelphia, PA, USA.
• Harshman LC Dana-Farber Cancer Institute, Boston, MA, USA.
• Alva A University of Michigan, Ann Arbor, MI, USA.
• Sternberg CN San Camillo Forlanini Hospital, Rome, Italy.
• Bamias A University of Athens, Athens, Greece.
• Grivas P Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
• Koshkin VS Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
• Roghmann F Ruhr-University Bochum, Marien Hospital Herne, Herne, Germany.
• Dobruch J Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland.
• Eigl BJ British Columbia Cancer Agency, Vancouver, BC, Canada.
• Nappi L British Columbia Cancer Agency, Vancouver, BC, Canada.
• Milowsky MI University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA.
• Niegisch G Heinrich-Heine-University, Medical faculty, Department of Urology, Düsseldorf, Germany.
• Pal SK City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
• De Giorgi U IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy.
• Recine F IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy.
• Vaishampayan U Karmanos Cancer Institute, Detroit, MI, USA.
• Berthold DD Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
• Bowles DW Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, CO, USA.
• Baniel J Rabin Medical Center, Petach Tikva, Israel.
• Theodore C Hospital Foch, Suresnes, France.
• Ladoire S Center Georges-François Leclerc, Dijon, France.
• Srinivas S Stanford University School of Medicine, Stanford, CA, USA.
• Agarwal N University of Utah, Salt Lake City, UT, USA.
• Crabb S University of Southampton, Southampton, United Kingdom.
• Sridhar S Princess Margaret Hospital, University Health Network, Toronto, Canada.
• Golshayan AR Medical University of South Carolina, Charleston, SC, USA.
• Ohlmann C Saarland University, Homburg, Germany.
• Xylinas E Cochin Hospital, Assistance-Publique Hôpitaux de Paris, Paris Descartes University, Paris, France.
• Powles T Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK.
• Rosenberg JE Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• Bellmunt J Dana-Farber Cancer Institute, Boston, MA, USA.
• van Rhijn B The Netherlands Cancer Institute, Amsterdam, The Netherlands.
• Galsky MD Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA.
• Hendricksen K The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Show more…

First-line chemotherapy

Postchemotherapy lymphadenectomy

Propensity-score

Urothelial carcinoma

Aged

Carcinoma, Transitional Cell

Chemotherapy, Adjuvant

Cystectomy

Humans

Lymph Node Excision

Lymph Nodes

Lymphatic Metastasis

Middle Aged

Neoplasm Staging

Pelvis

Progression-Free Survival

Propensity Score

Retroperitoneal Space

Retrospective Studies

Treatment Outcome

Urinary Bladder Neoplasms